EUiott (1) described an extraceUular proteolytic enzyme, streptococcal proteinase, in broth cultures of certain strains of group A streptococci grown under favorable cultural conditions. He observed that this enzyme digested the type-specific M protein antigen of group A streptococci as well as streptokinase, fibrin, milk, and casein. This enzyme was active under reducing conditions of bacterial growth; and in cell-free systems it was activated by cysteine, glutathione, potassium cyanide, and thioglycollie acid but was inactivated by iodoacetic acid and by normal mouse or rabbit serum. In a later report Elliott and Dole (2) found that the yield of active proteinase was greatest in broth containing undialyzed Pfanstiehl peptone and that cultures grown in media prepared with the dialysate of Pfanstiehl peptone or with undialyzed neopeptone produced the inactive precursor of streptococcal proteinase.
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(Received for publication, December 17, 1947) EUiott (1) described an extraceUular proteolytic enzyme, streptococcal proteinase, in broth cultures of certain strains of group A streptococci grown under favorable cultural conditions. He observed that this enzyme digested the type-specific M protein antigen of group A streptococci as well as streptokinase, fibrin, milk, and casein. This enzyme was active under reducing conditions of bacterial growth; and in cell-free systems it was activated by cysteine, glutathione, potassium cyanide, and thioglycollie acid but was inactivated by iodoacetic acid and by normal mouse or rabbit serum. In a later report Elliott and Dole (2) found that the yield of active proteinase was greatest in broth containing undialyzed Pfanstiehl peptone and that cultures grown in media prepared with the dialysate of Pfanstiehl peptone or with undialyzed neopeptone produced the inactive precursor of streptococcal proteinase.
Todd (3) also demonstrated a streptococcal enzyme in culture filtrates of many strains of group A streptococci and found it to be antigenic. It was considered probably identical with the one described by Elliott. It seemed important to determine the possible relationship of this newly discovered enzyme to the pathogenesis of streptococcal infections and their sequelae. A study was therefore undertaken to determine whether proteinase production by hemolytic streptococci isolated from patients with streptococcal infections as well as those isolated from normal carriers was in any way correlated with different types of clinical response. The capacity of various serological groups and types of hemolytic streptococci to elaborate proteinase was also investigated; and a study was made of the presence of proteinase as related to the presence of streptokinase in broth cultures of group A streptococci.
Materials and Methods
Source of Streptococcal Strains.raThe majority of the strains were isolated at the Hospital complications such as sinusitis, otitis media, peritonsillar abscess, cervical lymphadenitisj pneumonia, or impetigo; others developed rheumatic fever following their streptococcal infections. In a few instances both purulent complications and rheumatic fever were observed in the same patients. The cartier strains were cultured from rheumatic subjects and their siblings who developed no clinical evidence of disease and no streptococcal antibody response.
Other strains were isolated in the Chicago area at the Great Lakes Naval Training Station during the spring of 1946 from pharyngeal cultures of patients with streptococcal respiratory diseases including scarlet fever, some of whom later developed rheumatic fever. All these strains were frozen and dried shortly after isolation from the patients and kept in this state until used. A few lyophiliz~d streptococcal strains were selected from laboratory stock cultures to complete the series of all the known serological groups and types; these strains had probably in many instances been subcultured numerous times before lyophilization.
Grouping and Typing of Streptococcal Strains.--The hemolytic streptococci were classified into serological groups and types by the precipitin technique (4, 5) . In a few instances, strains which could not be classified by the precipitin method with the available sera were tested by cross-agglutination with homologous and heterologous rabbit antlsexa to determine whether they were antigenically similar or dissimilar.
Preparation of Cultures.--Each strain was seeded from the lyophilized stock of cultures into 5 cc. of Todd-Hewitt broth containing 2 per cent Pfanstiehl peptone or 1 per cent neopeptone and incubated in a water bath at 37°C. for 12 hours. A loopful of the actively growing culture was then transferred to 5 cc. of fresh broth and incubated for 28 hours at 37°C.
Determination of Proteinase Activity.--Pfanstlehl peptone broth was used exclusively to prepare cultures for determinations of proteinase activity unless otherwise stated. A method, described by Elliott and Dole (2) , which employs the coagulation of a milk-thioglycollate mixture was used in most experiments. Preliminary studies revealed that whole broth cultures gave results for proteinase assay comparable to those obtained with filtrates or supernates of these cultures. Because of simplicity, whole broth cultures were therefore employed. Control cultures were included in each series of tests, namely, a positive strain (K43) and a negative strain (K43 mouse passage).
In a few experiments the "azocoll" digestion technique (3) was carried out in parallel with the milk-thioglycollate method to estimate proteinase activity of streptococcal cultures.
Estimation of Streptokinase.--The method employed for the estimation of streptokinase was a modification of that described by Tillett, Edwards, and Garner (6) and the Commission on Acute Respiratory Diseases (7) .
The cultures of streptococci prepared for proteinase determination were tested for streptokinase by mixing gently 1.0 cc. of filtrate with 1.0 cc. of 0.6 per cent solution of a lyophil~ed fibrinogen, fraction I (Cohn) 1, from human plasma in physiological saline, buffered with veronal at pH 7.5 and 0.2 cc. of bovine thrombin in a 1 : 10 dilution of the same buffer. The mixtures were incubated in a water bath at 37°C. The streptokinase activity of the various strains was determined by liquefaction of the standard fibrin clot. Liquefaction was considered to have taken place when the clot moved or flowed freely on inversion of the tube. strains cultured from 144 patients or carriers between October, 1940, and April, 1947, 70 produced proteinase and 85 did not produce any of this enzyme. At different times 8 patients suffered more than one streptococcal infection. These were considered separate infections because the same serological type was not observed in the recurrent infections, and because significant rises in the antistreptolysin O titre of the patients' sera occurred. In the case of carriers, observations were confined to a single strain from each individual unless a change in serological type was observed. All streptococcal strains were isolated from nasopharyngeal cultures within 5 days after the onset of infection with the exception of those from 9 patients with a primary attck of rheumatic fever from whom cultures were not obtained until 2 to 4 weeks after infection. Seventy-three of the strains included in Table I were isolated from patients with scarlet fever. These are not grouped separately because the only difference between the patients with scarlet fever and those with pharyngitis alone was the erythematous rash.
OBSERVATIONS AND RESULTS

Proteinase Capacity of Group
Of 47 group A streptococcal strains cultured from patients who made uneventful recoveries from their acute pharyngitis, 25 strains produced proteinase and 22 failed to elaborate this enzyme. From patients with purulent complications, 15 group A streptococcal strains were isolated and all except one strain failed to produce proteinase. Ten of the 14 strains which did not elaborate the enzyme, however, were all serological type 19 and were isolated from the same epidemic. Apparently these strains were derived from a common source. Among 34 strains isolated from patients who developed a primary attack of acute rheumatic fever, 15 produced proteinase and 19 did not. In this group, 3 strains were cultured from patients who developed both purulent complications and rheumatic fever.
In Table I are also recorded the results of the proteinase capacity of a series of strains isolated from the nasopharynges of rheumatic subjects who suffered hemolytic streptococcal infections of the upper respiractory tract. The strains from those patients who developed a recurrence of rheumatic fever can be contrasted with strains isolated from patients who did not develop rheumatic fever following the streptococcal infection. Of 19 strains, each isolated from a different infection followed by an attack of rheumatic fever, 9 produced proteinase and 10 did not. Among the patients who did not develop rheumatic fever, there were 23 infections. Ten strains from these infections produced proteinase and 13 failed to show any activity.
One instance is of interest because the same strain, producing proteinase in ~itro, induced different clinical reactions in susceptible rheumatic subjects. A group A streptococcus of an unclassified type was cultured from a rheumatic subject with an attack of acute pharyngitis that was not followed by rheumatic fever; this same type caused an accidental respiratory infection in another rheumatic susceptible subject, who subsequently developed rheumatic fever.
The streptococci from these patients were shown to be the same type by crossagglutination tests with homologous and heterologous rabbit antisera. The proteinase capacity of streptococcal strains cultured from the throats of subjects who developed no apparent infection is also shown in Table I . These individuals were observed at 3 to 4 week intervals for several years, and no clinical or laboratory evidence of infection appeared when these strains were isolated. Moreover, no elevated titres for antistreptolysin 0, antifibrinolysin and, in a few cases studied, bacteriostatic antibodies were observed in the sera * Ten of these strains were isolated from the same epidemic and were of the same serological type. of these subjects. Of 17 strains from these individuals, 10 strains had demonstrable proteinase activity but 7 were proteinase-negative.
Upon consideration of the data presented in this table, there appears to be no evidence that proteinase-or non-proteinase-producing strains were associated with any particular variety of streptococcal infectious process: Strains with or without proteinase activity were each isolated from normal carriers or from patients who developed rheumatic fever, purulent processes, or uncomplicated infections.
Proteinase Production of Epidemic, Endemic, and Carrier Strains of Group A
Streptococci.--An opportunity presented itself to investigate the proteinase capacity of epidemic, endemic, and carrier strains of various serological types of group A streptococci. The epidemic strains were isolated from young adult Naval personnel in New York City from 1942-44 and in the Chicago area during 1945. The endemic and carrier strains were obtained during 194(}-47 from children and young adults in New York City who were in no contact with those from whom the epidemic strains were cultured. In Table II is shown the proteinase production of these 3 groups of strains. A variety of serological types are represented in each group and the time of isolation is spread over relatively similar dates. Twelve of the endemic and 11 of the carrier strains could not be typed by the precipitin method with the available sera, and are therefore not included in the number of serological types but are included in the number of strains investigated.
It is apparent from the results shown in Table II 10 7
*Twelve of the endemic and 11 of the carrier strains could not be typed with available sera; the number of types represented by the remainder is indicated in the third colnm,,, mately an equal distribution of proteinase-and non-proteinase-producing strains. Moreover, it can be seen that 16 different serological types are included in the epidemic group. If, on the other hand, a single serological type from an epidemic and, presumably, from a common source is assayed, a uniform pattern of proteinase production will be observed. Examples of this will be presented in Table III .
Lack of Correlation between Proteinase Capacity of Serological Types of Group A Streptococci and Clinical Manifestations.--To ascertain whether there is any
correlation between the proteinase activity of strains belonging to a single type and the clinical reaction to infections induced by these strains, numerous serological types of streptococci were studied. In Table III are presented 5 representative examples to illustrate the proteiuase production of strains of the same serological type cultured from patients whose clinical response to streptococcal infections varied. It can be seen that the serological types 1, 3, and 19 comprise both proteinase-and non-proteinase-produCing strains; and in these types, strains of the same serological type and proteinase activity frequently induced different clinical manifestations. The same thing was observed with PRODUCTION 
O~ PROTEINASE BY HEMOLYTIC STREPTOCOCCI
the type 30 strains all of which, isolated from a single epidemic, produced proteolytic enzyme. In contrast to this, most of the type 17 strains, chiefly from the same epidemic, did not produce proteinase but were, nevertheless, able to initiate a variety of clinical effects.
On the other hand, as exemplified in type 19 (Table III) , strains of the same serological type but differing in their ability to produce proteinase, were often found to give rise to the same clinical manifestations in different patients. Similar results were obtained with 17 other serological types not recorded in Table III . I t is noteworthy that serological types 14, 19, and 26 included strains which produced no proteir~se and were each associated with either the presence or absence of rheumatic fever recurrences in susceptible subjects. The majority of the strains belonging to the serological types 17, 19, and 30 which showed uniformly positive or negative proteinase activity were isolated during epidemics of streptococcal infections and are probably derived from common sources. The fact that these epidemic strains of the same serological type each had their origin from a single parent strain and induced a variety of clinical reactions to infection emphasizes the lack of correlation between the proteinase capacity of the serological type and the disease state.
Comparison of Proteinase Capacity of Strains Isolated in Acute and Convalescent Phases of Infection~-A series of strains isolated from patients at weekly
intervals during the acute phase of illness through convalescence was selected to determine whether any change in proteinase capacity occurred. In the test for this activity the time at which coagulation of the milk first occurred gave a roughly quantitative estimate of proteinase production. Eight serial weekly cultures from a patient with a type 38 infection and 12 from a patient with a type 26 infection showed a uniformly negative response when tested for proteinase production; 5 weekly cultures from a patient with a type 12 infection, 8 from a patient infected with an unclassified strain, and 6 cultures from a patient with a type 30 infection showed positive reactions which were quantitatively consistent. In addition, from 4 to 7 weekly cultures of 3 sulfadiazineresistant strains from patients with type 17 infections were tested for consistency of enzyme production by cultures isolated in the acute phase through convalescence. None of these cultures produced proteinase.
The majority of the patients from whom epidemic strains were obtained at the Hospital of the Rockefeller Institute received therapeutic doses of sulfadlazine for 7 to 14 days in an effort to clear up the carrier state or purulent complications. Cultures were taken from patients both before and after sulfadiazine therapy to observe any possible change in enzyme production due to the action of the drug. Proteinase-positive cultures were isolated both before and after therapy from 4 patients, two with type 23 infections, and one each with a type 30 and a type 3 infection. Proteinase-negative strains were similarly isolated from 6 patients, 3 with type 19 infections and 3 with infections of types 6, 14, and 38 respectively. In all cases the proteinase activity remained unchanged. The remarkable uniformity of proteinase production of these strainswhile they remained in the nasopharynx of patients suggests that the capacity to produce this enzyme is reasonably stable.
Proteinase Production by Various Serological Groups and Types of Hemolytic
Streptococci~To determine the relationship between the serological groups and types of hemolytic streptococci and proteinase production, a series of strains were tested from multiple sources which included the strains of group A strep' tococci previously considered in this report. In addition, other strains selected from laboratory stock cultures kept in the lyophilized state for many years were included.
A total of 238 strains, of which 208 belonged to group A and 30 to other established Lancefield groups, 2 was assayed. There were 41 known serological types of group A streptococci represented; and 23 group A strains were not classified into types with the available sera. The capacity to clot milk appeared to be limited to group A strains with the exception of one group D strain, D76, probably bovine in origin, and one group M strain, D168A"X", isolated from the vagina of a normal dog. Both of these strains were tested in Groups B, C, D, E, F, G, H, K, L, M. duplicate and on different days; in each test, milk was clotted between 4 and 24 hours. The pH of the cultures was 6.8, which excludes acid clotting of the milk. The possibility that some other enzyme system might also cause clotting of milk must be considered. Certain group D strains, notably S. liquefa¢iens, are known to have proteolytic properties which may be different from the one studied in group A streptococci.
Of 208 group A strains tested, 107 or 51 per cent produced the enzyme. Since 23 strains could not be typed, a total of 185 strains, distributed among 41 different serological types of group A streptococci, is tabulated in Table  IV . Of the types represented, 35 had more than one strain and of these, i i types (1, 2, 3, 4, 17, 19, 24, 28, 29, 43 , and 46) comprised both proteinasepositive and negative strains. The large number of positive-or negativeenzyme-producing strains in types 17, 19, and 30 is due to the fact that they are epidemic strains and probably originated from a common strain of the corresponding type. From these data it appears that many of the serological types of group A streptococci include strains capable of producing proteinase and others which do not produce this enzyme. However, further studies are necessary before such variations can be established as characteristic of the type. Elliott (1) has demonstrated that streptococcal proteinase digests streptokinase, the relationship of these enzymes in cultures was investigated. In Table V is shown the reciprocal relationship between the presence of proteinase and the demonstration of streptokinase in cultures of various strains of hemolytic streptococci grown in Pfanstiehl peptone broth. The proteinase production was determined by both the milk-coagulation and azocoll tests; and the results of the measurement by these two methods were identical. The pH of the filtrates varied from 5.9 to 6.3. The reaction was never low enough to cause acid clotting of milk. A total of 37 strains of 9 different serological types of group A streptococci was tested in Pfanstiehl broth. Of these, 20 strains produced proteinase and no streptokinase, while 17 strains were proteinase-negative and streptokinase-positive.
Relationship between the Presence of Proteinase and Streptokinase in Broth Cultures.--Since
In the present study advantage was taken of the observations of Elliott and Dole (2) to determine whether the reciprocal relationship between the presence of proteinase and streptokinase would be maintained in both Pfanstiehl and neopeptone broth. Ten strains of 5 different serological types were tested in both broths. In 7 of these strains, proteinase but no streptokinase was found in Pfanstiehl broth, and streptokinase but no proteinase was detected in neopeptone broth. The results in the other 3 strains were variable. It appears that in strains which produce both proteinase and streptokinase the reciprocal relationship between these two streptococcal components is, in most cases, dependent on the conditions in the culture media suitable for the production of the inactive or active proteinase: Thus in neopeptone broth the streptococcal 33  34  35  36  37  38  39  40  41  42  43  44  46  47   5  2  8  3  3  7  3  2  2  3  3  5  3  16"  3  44*  3  3  6  1  5  1  3  3  13"  2  3  3  1  2  3  1  3  1  3  1  2  3  3  3  1   Positive   2  1  5  1  3  0  3  2  2  3  3  0  3  1  0  7  3  3  5  1  0  1  2  1  13  2  0  3  0  2  3  0  0  1  3  1  2  2 * The majority of these cultures were epidemic strains and in each typewere probably derived from one or two sources. cells produce the proteinase as a precursor which is inactive and streptokinase is not digested; whereas in Pfanstiehl broth, the active proteinase is formed and the streptokinase is digested.
DISCUSSION
A unique opportunity was provided for obtaining epidemic strains of several serological types of group A streptococci from patients with a variety of clinical responses to infection. These strains were isolated from young adults in the second decade of life who lived under similar conditions while in Naval service. Moreover, a relatively large number of these epidemic strains were of a few serological types, in each of which the capacity of the streptococci to produce proteinase was uniform. The epidemic conditions suggested common origins for the strains within each type and made possible a study of the effect of proteinase production upon the clinical manifestations in patients, uncomplicated by other differences in the streptococci.
The data obtained revealed no evidence that proteinase or non-proteinase--producing epidemic strains of various serological types were associated with any particular variety of infectious process. This was indicated by the fact that strains of the same serological type and proteinase activity were isolated from patients who developed various clinical manifestations. On the other hand, strains which differed only in their ability to produce proteinase showed no difference in the pathologic conditions evoked in individual patients.
An especially suitable series of streptococcal strains from endemic sources was available for comparison with the epidemic strains described above. The endemic and carrier strains were derived from individuals who had had previous attacks of rheumatic fever and from their siblings. All of this group were followed constantly for several years as previously reported (8) . Since a study of these strains showed the same findings as those from epidemic sources, it appears to be a general phenomenon that there is no correlation between the capacity of group A streptococci to produce proteinase and the clinical reactions of the patients to infection with these strains.
The possibility was considered that strains long resident in the throats of patients convalescing from infection might change in their function to elaborate this enzyme. Rather than any change being observed, a remarkable stability of these strains to produce a quantitatively uniform amount of enzyme over long periods was demonstrated. This stability was apparent even in the presence of therapeutic doses of suifadiazine administered to the patient.
The capacity to produce proteinase appears to be related to the strain rather than to the serological type, as indicated by the occurrence of both enzymeand non-enzyme-producing strains in many of the serological types. In some of the types investigated, all of the strains were similar in their ability to produce enzyme. The fact that in each instance there was intermingling of Naval Personnel between stations in which epidemics occurred suggests that these strains were probably derived from a common parent strain in each type.
To determine whether proteinase production is characteristic of individual types, it will be necessary to test many more strains from unrelated sources. In considering this relationships it is of interest that Todd (3) found proteinase activity in concentrated filtrates which showed no activity before concentration. This suggested that most strains may produce the enzyme under suitable conditions.
The reciprocal relationship between the presence of proteinase and that of streptokinase in streptococcal cultures revealed a situation analogous to that observed by EUiott (1) with the type-specific NI antigen of group A streptococci. Proteinase digests both streptokinase and the M protein; therefore, the two latter streptococcal components are not usually found in the same cultures with proteinase. Nevertheless, it has been observed that occasionally streptokinase may be present in small amounts simultaneously with proteinase, a situation also found to hold true with regard to the balance between the presence of M protein and proteinase in the same system (1). In the case of the two enzymes, one of which destroys the other, presumably the streptococcal cell may maintain constantly its function of producing both, but the balance between their relative concentrations is determined by the conditions prevailing in the culture at the time of testing.
